Apr 10, 2018 12:00 pm UTC| Business
NEW YORK, April 10, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Nova Measuring...
Apr 10, 2018 12:00 pm UTC| Business
CAMBRIDGE, Mass. and TORONTO, April 10, 2018 -- Wave Life Sciences Ltd. (NASDAQ:WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases, and...
Apr 10, 2018 12:00 pm UTC| Business
EXTON, Pa., April 10, 2018 -- Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today announced that John...
Apr 10, 2018 12:00 pm UTC| Business
3-month Phase 2 data indicate SEL-212 (SVP-Rapamycin + pegsiticase) product profile may provide better and more sustained serum uric acid control, fewer flares, and less frequent dosing compared with recent data reported...
Velano Vascular to Address Healthcare Innovation at Upcoming Spring Conferences
Apr 10, 2018 12:00 pm UTC| Business
SAN FRANCISCO, April 10, 2018 -- Vascular access technology innovator Velano Vascular today announced that company leadership will present at a number of premier healthcare conferences in the second quarter. Chief...
CareDx Launches HeartCare® for Heart Transplant Recipients
Apr 10, 2018 12:00 pm UTC| Business
BRISBANE, Calif., April 10, 2018 -- CareDx, Inc. (NASDAQ:CDNA), a molecular diagnostics company focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions...
Apr 10, 2018 12:00 pm UTC| Business
BASKING RIDGE, N.J., April 10, 2018 -- Caladrius Biosciences, Inc. (Nasdaq:CLBS) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms targeting autoimmune and...